Document:

Exhibit 10.2

THIS PROMISSORY NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED. THE NOTE HAS BEEN ACQUIRED FOR INVESTMENT AND MUST BE HELD
INDEFINITELY and MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS IT
IS SUBSEQUENTLY REGISTERED UNDER SAID ACT or, in the opinion of counsel to the
company, an exemption from registration under said act is available.

                                 PROMISSORY NOTE
                                 ---------------

$100,000                                                         August 30, 2004

FOR VALUE RECEIVED, Phase III Medical, Inc., a Delaware corporation,
("Maker") promises to pay to Robert Aholt ("Payee"), in lawful money of the
United States of America, the principal sum of One Hundred Thousand Dollars
($100,000.00 ), together with interest thereon accruing at an annual rate equal
to 20%, in the manner provided below. Interest shall be calculated on the basis
of a year of 365 or 366 days, as applicable, and charged for the actual number
of days elapsed.

1.       PAYMENTS

         1.1  Principal and interest.

         Interest on the unpaid principal amount shall be payable monthly in
         arrears until the entire principal amount shall be paid in full.
         All principal and accrued interest shall be paid in full on
         February 28, 2005 (6 months after the date of issuance of this
         Note).

         1.2  Manner of Payment

              All payments of principal and interest on this Note shall be
              made by check at Robert Aholt, 20128 Cavern Court, Saugus,
              CA, 91390, or at such other place in the United States of
              America as Payee shall designate to Maker in writing. If any
              payment of principal or interest on this Note is due on a
              day which is not a Business Day, such payment shall be due
              on the next succeeding Business Day. "Business Day" means
              any day other than a Saturday, Sunday or legal holiday in
              the State of New York.

<PAGE>

         1.3  Prepayment

              Maker may, without premium or penalty, at any time and from time
              to time, prepay all or any portion of the outstanding
              principal balance due under this Note, provided that each
              such prepayment is accompanied by accrued interest on the
              amount of principal prepaid calculated to the date of such
              prepayment.

              Any partial prepayments shall be applied first to accrued interest
              and then to principal.

2.       DEFAULTS

         2.1  Events of Default

              The occurrence of any one or more of the following events with
              respect to Maker shall constitute an event of default
              hereunder ("Event of Default"):

               (a)  If Maker shall fail to pay when due any payment of principal
                    or interest on this Note.

               (b)  If, pursuant to or within the meaning of the United States
                    Bankruptcy Code or any other federal or state law relating
                    to insolvency or relief of debtors (a "Bankruptcy Law"),
                    Maker shall (i) commence a voluntary case or proceeding;
                    (ii) consent to the entry of an order for relief against it
                    in an involuntary case; (iii) consent to the appointment of
                    a trustee, receiver, assignee, liquidator or similar
                    official; (iv) make an assignment for the benefit of its
                    creditors; or (v) admit in writing its inability to pay its
                    debts as they become due.

               (c)  If a court of competent jurisdiction enters an order or
                    decree under any Bankruptcy Law that (i) is for relief
                    against Maker in an involuntary case; (ii) appoints of a
                    trustee, receiver, assignee, liquidator or similar official
                    for the Maker or substantially all of the Maker's
                    properties; or (iii) orders the liquidation of the Maker,
                    and in each case the order is not dismissed within 90 days.

         2.2  Remedies

              Upon the occurrence of an Event of Default hereunder (unless all
              Events of Default have been cured or waived by Payee), Payee
              may, at its option, (i) by written notice to Maker, declare
              the entire unpaid principal balance of this Note, together
              with all accrued interest thereon, immediately due and
              payable, and (ii) exercise all and any rights and remedies
              available to it under applicable law, including, without
              limitation, the right to collect from maker all sums due
              under this Note. Maker shall pay all reasonable costs and
              expenses incurred by or on behalf of Payee in connection
              with Payee's exercise of any or all of its rights and
              remedies under this Note, including, without limitation,
              reasonable attorneys' fees and expenses.

<PAGE>

3.       REPRESENTATIONS BY PAYEE

         Payee represents and warrants to Maker as follows:

          (a)  Payee has received and examined all information, including
               financial statements, of or concerning Maker which Payee
               considers necessary to making an informed decision regarding this
               Note. In addition, Payee has had the opportunity to ask questions
               of, and receive answers from, the officers and agents of Maker
               concerning Maker and to obtain such information, to the extent
               such persons possessed the same or could acquire it without
               unreasonable effort or expense, as Payee deemed necessary to
               verify the accuracy of the information referred to herein.

          (b)  The Payee acknowledges and understands that (i) the Maker will
               use the proceeds of this Note in its the establishment of new
               business operations; (ii) the proceeds of this Note will not be
               sufficient to provide Maker with the necessary funds to achieve
               its current business plan; (iii) the Maker does not have
               sufficient cash available to repay this Note; (iv) this Note will
               not be guaranteed nor will it be secured by any assets of Maker
               nor senior to any other indebtedness of Maker; and (v) Payee
               bears the economic risk of never being repaid on this Promissory
               Note.

          (c)  The Payee hereby certifies that Payee is an "Accredited Investor"
               (as that term is defined by Regulation D under the Securities Act
               of 1933, as amended) because at least one of the following
               statements is applicable to Payee:

               (i)  Payee is an Accredited Investor because the Payee had
                    individual income of more than $200,000 in each of the two
                    prior calendar years and reasonably expects to have
                    individual income in excess of $200,000 during the current
                    calendar year.

               (ii) The Payee is an Accredited Investor because the Payee and
                    his spouse together had income of more than $300,000 in each
                    of the two prior calendar years and reasonably expect to
                    have joint income in excess of $300,000 during the current
                    calendar year.

               (iii) The Payee is an Accredited Investor because the Payee has
                    an individual net worth, or the Payee and his spouse have a
                    joint net worth of more than $1,000,000.

          (d)  Payee is acquiring this Note for his own account, for investment
               purposes only, and not with a view to the resale or distribution
               of all or any part thereof.

<PAGE>

          (e)  Payee acknowledges that this Note (i) has not been registered
               under applicable securities laws, (ii) will be a "restricted
               security" as defined in applicable securities laws, (iii) has
               been issued in reliance on the statutory exemptions from
               registration contemplated by applicable securities laws based (in
               part) on the accuracy of Payee's representations contained
               herein, and (iv) will not be transferable without registration
               under applicable securities laws, unless an exemption from such
               registration requirements is available.

          (f)  Payee has reviewed and understands Maker's (i) Annual Report on
               Form 10-K for the fiscal year ended December 31, 2003; (ii)
               Quarterly Reports on Form10-Q for the quarters ended March 31,
               June 30, September 30, 2003, and March 31, June 30, 2004; (iii)
               proxy statement for its 2003 annual meeting of shareholders and
               (iv) all Current Report on Form 8-K filed since the filing of its
               last Form 10-K.

4.       MISCELLANEOUS

         4.1  Waiver

              The rights and remedies of Payee under this Note shall be
              cumulative and not alternative. No waiver by Payee of any
              right or remedy under this Note shall be effective unless it
              is in writing and signed by Payee. Neither the failure nor
              any delay in exercising any right, power or privilege under
              this Note will operate as a waiver of such right, power or
              privilege and no single or partial exercise of any such
              right, power or privilege by Payee will preclude any other
              or further exercise of such right, power or privilege or the
              exercise of any other right, power or privilege. To the
              maximum amount permitted by applicable law, (i) no claim or
              right of Payee arising out of this Note can be discharged by
              Payee, in whole or in part, by a waiver or renunciation of
              the claim or right unless in a writing, signed by Payee; (b)
              no waiver that may be given by Payee will be applicable
              except in the specific instance for which it is given; and
              (c) no notice to or demand on Maker will be deemed to be a
              waiver of any obligation of Maker or of the right of Payee
              to take further action without notice or demand as provided
              in this Note.

              Maker acknowledges that this Note and Maker's obligations under
              this Note are, and shall at all times continue to be,
              absolute and unconditional in all respects, and shall at all
              times be valid and enforceable. To the extent permitted by
              applicable law, Maker hereby absolutely, unconditionally and
              irrevocably forever waives any and all right to assert any
              defense, set-off, off-set, counterclaim, cross-claim, or
              claim of any nature whatsoever with respect to this Note or
              Maker's obligations hereunder.

<PAGE>

         4.2  Notices

              Any notice or communication to be given hereunder by any party,
              to the other party shall be in writing and shall be deemed
              to have been given when personally delivered, or one day
              after the date sent by recognized overnight courier or
              transmitted by facsimile, which transmission by facsimile
              has been confirmed or 3 (three) days after the date sent by
              registered or certified mail, postage prepaid, as follows:

                  If to Maker, addressed to it at:

                  Phase III Medical, Inc.
                  330 South Service Road
                  Suite 120
                  Melville, NY 11747
                  Attn:    Mark Weinreb
                  Facsimile Number: (631) 574 4956

                  If to Payee, addressed to:

                  Name:  Robert Aholt
                Address: 20128 Cavern Court
                         Saugus, CA  91390

              Or persons or addresses as may be designated in writing by the
              party to receive such notice.

         4.3  Severability

              If any provision of this Note is held invalid or unenforceable
              by any court of competent jurisdiction, the other provisions
              of this Note will remain in full force and effect. Any
              provision of this Note held invalid or unenforceable only in
              part or degree will remain in full force and effect to the
              extent not held invalid or unenforceable.

         4.4  Governing Law.

              This Promissory Note will be governed by the laws of the State of
              New York without regard to conflicts of laws principles.

<PAGE>

         4.5  Assignment; Parties in Interest

              This Note shall bind Maker and its successors and assigns. This
              Note shall not be assigned or transferred by Maker, without
              the express prior written consent of Payee, and this Note
              will inure to the benefit of Payee and his heirs, estates,
              representatives, administrators, successors and assigns.

         4.6  Section Headings, Construction

              The headings of Sections in this Note are provided for
              convenience only and will not affect its construction or
              interpretation. All references to "Section" or "Sections"
              refer to the corresponding Section or Sections of this Note
              unless otherwise specified.

              All words used in this Note will be construed to be of such
              gender or number as the circumstances require. Unless
              otherwise expressly provided, the words "hereof" and
              "hereunder" and similar references refer to this Note in its
              entirety and not to any specific section or subsection
              hereof.

         4.7  Savings Clause

              If, at any time, the rate of interest under this Note shall be
              deemed by any competent court of law, governmental agency or
              tribunal to exceed the maximum rate of interest permitted by
              the laws of any applicable jurisdiction or the rules or
              regulations of any regulatory authority or agency, then
              during such time as such rate of interest would be deemed
              excessive, that portion of each interest payment
              attributable to that portion of such interest rate that
              exceeds the maximum rate of interest so permitted shall be
              deemed a voluntary prepayment of principal or, if all
              principal has been paid, that portion of each interest
              payment attributable to that portion of such interest rate
              that exceeds the maximum rate of interest so permitted shall
              be promptly refunded to Maker.

          4.8  Waiver of Jury Trial

               MAKER AND PAYEE EACH HEREBY WAIVE, TO THE FULLEST EXTENT
               PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A
               TRAIL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR
               INDIRECTLY ARISING OUT OF, UNDER, OR IN CONNECTION WITH,
               THIS NOTE, IT BEING AGREED THAT ALL SUCH TRAILS SHALL BE
               CONDUCTED SOLELY BY A JUDGE. MAKER AND PAYEE EACH CERTIFY
               THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF EITHER HAS
               REPRESENTED, EXPRESSLY OR OTHERWISE, THAT THE OTHER WOULD
               NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE
               FOREGOING WAIVERS. MAKER AND PAYEE EACH AGREE AND
               ACKNOWLEDGE THAT IT HAS BEEN REPRESENTED BY INDEPENDENT
               COUNSEL IN CONNECTION WITH THIS NOTE OR BEEN ADVISED THAT IT
               SHOULD BE REPRESENTED BY INDEPENDENT COUNSEL IN CONNECTION
               WITH THIS NOTE. IF MAKER OR PAYEE HAS DECIDED NOT TO BE
               REPRESENTED BY INDEPENDENT COUNSEL IN CONNECTION WITH THIS
               NOTE, IT IRREVOCABLY AND FOREVER WAIVES ANY AND ALL DEFENSES
               OR RIGHTS ARISING OUT OF OR RELATED TO SAID DECISION.

<PAGE>

     IN WITNESS WHEREOF, Maker has executed and delivered this Note as of the
date first stated above.

                             PHASE III MEDICAL, INC.

                              By: /s/ Mark Weinreb
                                  ----------------
                            Name: Mark Weinreb
                           Title: President and Chief Executive Officer

Accepted and agreed to:

/s/ Robert Aholt
----------------
Payee: Robert AholtExhibit 10.3
                                                                    ------------

                             PHASE III MEDICAL, INC.
                             330 South Service Road
                                    Suite 120
                            Melville, New York 11747
                                  631 574.4955

September 13, 2004

Mr. Robert Aholt, Jr.
20128 Cavern Court
Saugus, California 91390

Dear Mr. Aholt:

     We are pleased to extend to you an invitation to become the Chief Operating
Officer ("COO") of Phase III Medical, Inc. (the "Company").

     As you know, the Company is a public company that, among other things,
provides capital and guidance to companies, within the medical sector, in
exchange for revenues, royalties and other contractual rights known as "royalty
interests," that entitle it to receive a portion of revenue from the sale of
pharmaceuticals, medical devices and biotechnology products. As COO, you will be
responsible for assisting the Company in reviewing and evaluating business,
scientific and medical opportunities, and for other discussions and meetings
that may arise during the normal course of the Company conducting its business.

     This Letter Agreement shall be effective as of September 13, 2004 (the
"Commencement Date") and shall continue for a period of three (3) years from the
Commencement Date (the "Term"). For all services rendered by you in any capacity
required hereunder during the Term, you shall be entitled to a monthly salary of
$4,000 during the first year of the Term, $5,000 during the second year of the
Term, and $6,000 during the third year of the Term, payable within normal
payroll practices of the Company, provided that all conditions to payment
specified herein have been met.

     In further consideration for your services hereunder, on January 1, 2005
and on the first day of each calendar quarter thereafter during the Term, the
Company shall grant you a number of shares of common stock, $0.001 par value per
share, of the Company ("Common Stock"), with a "Dollar Value" of $26,750.00,
$27,625.00 and $28,887.50, respectively, during the first, second and third
years of the Term. The per share price (the "Price") of each share granted to
determine the Dollar Value shall be the average closing price of one share of
Common Stock on the National Association of Securities Dealers, Inc.
Over-the-Counter Bulletin Board (the "Bulletin Board") (or other similar
exchange or association on which the Common Stock is then listed or quoted) for
the five (5) consecutive trading days immediately preceding the date of grant of
such shares; provided, however, that if the Common Stock is not then quoted on
the Bulletin Board or otherwise listed or quoted on an exchange or association,
the Price shall be the fair market value of one share of Common Stock as of the
date of grant as determined in good faith by the Board of Directors of the
Company. The number of shares of Common Stock for each quarterly grant shall be
equal to the quotient of the Dollar Value divided by the Price. The shares
granted will be subject to a one year lockup as of the date of each grant.

<PAGE>

     At the end of each year, the parties will discuss variations in the cash
and stock proportions of your compensation. In the absence of an alternative
mutual agreement, the foregoing shall apply.

     Your employment with the Company shall automatically terminate upon your
death or Disability (as defined below). The Company may terminate your
employment prior to the end of the Term with or without Cause (as defined below)
immediately upon written notice to you. You may terminate your employment upon
thirty (30) days' prior written notice to the Company. For purposes of this
Letter Agreement, the terms set forth below shall have the meanings ascribed to
them below:

     "Cause" shall mean (i) willful malfeasance or willful misconduct by you in
      connection with your employment; (ii) your gross negligence in
      performing any of your duties under this Letter Agreement; (iii) your
      conviction of, or entry of a plea of guilty to, or entry of a plea of
      nolo contendre with respect to, any crime other than a traffic
      violation or infraction which is a misdemeanor; (iv) your material
      breach of any written policy applicable to all employees adopted by
      the Company that is not cured to the reasonable satisfaction of the
      Company within fifteen (15) business days after notice thereof; or (v)
      material breach by you of any of your agreements in this Letter
      Agreement which is not cured to the reasonable satisfaction of the
      Company within fifteen (15) business days after notice thereof.

     "Disability" shall mean your inability to perform an essential function of
      your duties and responsibilities to the Company by reason of a
      physical or mental disability or infirmity, which inability has
      continued for a period of more than six (6) consecutive months, or for
      a period aggregating more than six (6) months, whether or not
      continuous, during any nine (9) month period. The existence of a
      Disability shall be determined by the Company in its absolute
      discretion.

     "Good Reason" shall mean (i) the Company's reassignment of your base of
      operations outside of Los Angeles, California without your consent,
      (ii) the material reduction by the Company of your duties during the
      Term, (iii) the Company's material breach of the Company's obligations
      under this Letter Agreement, or (iv) the Company not retaining you as
      COO.

<PAGE>

     In the event your employment is terminated prior to the end of the Term due
to your death or Disability, by the Company with or without Cause or upon your
resignation from your position as COO for Good Reason, earned but unpaid cash
compensation and unreimbursed expenses due as of the date of such termination
(the "Employment Termination Date") shall be payable in full. In addition, in
the event your employment is terminated prior to the end of the Term for any of
the reasons identified in the preceding sentence other than by the Company with
Cause, you or your executor of your last will or the duly authorized
administrator of your estate, as applicable, will be entitled (i) to receive
severance payments equal to one year's salary, paid at the same level and timing
of salary as you are then currently receiving and (ii) to receive, during the
one (1) year period following the Employment Termination (the "Severance
Period"), the stock grants that you would have been entitled to receive had your
employment not been terminated prior to the end of the Term; provided, however,
that in the event such termination is by the Company without Cause or is upon
your resignation for Good Reason, such severance payment and grant shall be
subject to your execution and delivery to the Company of a release of all claims
against the Company. No other payments shall be made, nor benefits provided, by
the Company in connection with the termination of employment prior to the end of
the Term, except as otherwise required by law.

     The Company shall pay or reimburse you for all reasonable travel or other
expenses (including, without limitation, digital subscriber line (DSL), car (at
$750 per month), cell phone and insurance expenses) incurred by you in
connection with the performance of your duties and obligations under this Letter
Agreement, subject to your presentation of appropriate vouchers in accordance
with such procedures as the Company may from time to time establish (including
any procedures established to preserve any deductions for Federal income
taxation purposes to which the Company may be entitled). I will also pay the
executive search firm that you engaged up to $5,000 of the amounts that you owe
to such firm.

     All payments provided for under this Letter Agreement shall be paid in cash
from the general funds of the Company. The Company shall not be required to
establish a special or separate fund or other segregation of assets to assure
such payments, and, if the Company shall make any investments to aid it in
meeting its obligations hereunder, you shall have no right, title or interest
whatever in or to any such investments except as may otherwise be expressly
provided in a separate written instrument relating to such investments.

     You acknowledge that, as COO, you will have access to the Company's
confidential information and that all confidential information shall be and
remain the sole property of the Company and that you will not at any time, now
or in the future, disclose, disseminate or otherwise make public any of the
confidential information without the express written permission of the Company.

     You acknowledge and agree that your services pursuant to this Letter
Agreement are unique and extraordinary; that the Company will be dependent upon
you for development, financial, marketing and other expertise; and that you will
have access to and control of confidential information of the Company. You
further acknowledge that the business of the Company is international in scope
and cannot be confined to any particular geographic area. You further
acknowledge that the scope and duration of the restrictions set forth in this
paragraph are reasonable in light of the specific nature and duration of the
transactions contemplated by this Letter Agreement. For the foregoing reasons
and to induce the Company to enter this Letter Agreement, you covenant and agree
that during the Term and the period beginning at the end of the Term and ending
one (1) year after the end of the Term, you shall not unless with written
consent of the Company:

<PAGE>

          (i)  engage in any business directly related to the business of
               providing capital and guidance to companies, within the medical
               pharmaceutical and biotechnology sector, or in any other business
               conducted by the Company during the Term (collectively, the
               "Prohibited Activity") in the world for your own account;

          (ii) become interested in any individual, corporation, partnership or
               other business entity (a "Person") engaged in any Prohibited
               Activity in the world, directly or indirectly, as an individual,
               partner, shareholder, officer, director, principal, agent,
               employee, trustee, consultant or in any other relationship or
               capacity; provided, however, that you may own directly or
               indirectly, solely as an investment, securities of any Person
               which are traded on any national securities exchange if you (x)
               are not a controlling person of, or a member of a group which
               controls, such person or (y) do not, directly or indirectly, own
               5% or more of any class of securities of such person; or

          (iii) directly or indirectly hire, employ or retain any person who at
               any time during the last twelve (12) months of the Term was an
               employee of the Company or directly or indirectly solicit,
               entice, induce or encourage any such person to become employed by
               any other person.

     You hereby acknowledge that the covenants and agreements contained in the
immediately preceding paragraph are reasonable and valid in all respects and
that the Company is entering into this Letter Agreement on such acknowledgment.
If you breach, or threaten to commit a breach, of any of the restrictive
covenants set forth in this Letter Agreement (the "Restrictive Covenants"), the
Company shall have the following rights and remedies, each of which rights and
remedies shall be independent of the other and severally enforceable, and all of
which rights and remedies shall be in addition to, and not in lieu of, any other
rights and remedies available to the Company under law or in equity: (i) the
right and remedy to have the Restrictive Covenants specifically enforced by any
court having equity jurisdiction, it being acknowledged and agreed that any such
breach or threatened breach will cause irreparable injury to the Company and
that money damages will not provide an adequate remedy to the Company; and (ii)
the right and remedy to require you to account for and pay over to the Company
such damages as are recoverable at law as the result of any transactions
constituting a breach of any of the Restrictive Covenants.

     You hereby represent and warrant that (i) you have the legal capacity to
execute and perform this Letter Agreement, (ii) this Letter Agreement is a valid
and binding agreement enforceable against you according to its terms, (iii) the
execution and performance of this Letter Agreement does not violate the terms of
any existing agreement or understanding to which you are a party or by which you
may be bound and (iv) you have, and will, maintain during the Term, all
requisite licenses, permits and approvals necessary to perform the duties of COO
set forth herein. You also hereby agree that you shall not participate in any
medical, health, and insurance plans which may from time to time be in effect
for employees of, or consultants to, or other agents of, the Company. You hereby
acknowledge to the Company that you desire to, and are capable of, securing such
benefits independent of your relationship with the Company.

<PAGE>

     This Letter Agreement shall be governed by, and construed in accordance
with, the internal laws of the State of New York, without reference to the
choice of law principles thereof. Any claim, controversy or dispute between the
parties hereto, arising out of, relating to, or in connection with this Letter
Agreement or any aspect of your services to the Company hereunder, including but
not limited to the termination of this Letter Agreement and any and all claims
in tort or contract, shall be submitted to arbitration in Melville, New York,
pursuant to the American Arbitration Association ("AAA") National Arbitration
Rules for the Resolution of Employment Disputes. This provision shall apply to
claims against the Company and/or its affiliates and their respective current or
former employees, agents, managers, officers and/or directors. Any issue about
whether a claim is covered by this Letter Agreement shall be determined by the
arbitrator. There shall be one arbitrator, who (a) shall be chosen from a panel
provided by the AAA and who shall apply the substantive law of the State of New
York, (b) may award injunctive relief or any other remedy available from a
judge, including attorney fees and costs to the prevailing party, and (c) shall
not have the power to award punitive damages. Judicial review of the
arbitrator's award shall be strictly limited to the issue of whether said award
was obtained through fraud, corruption or misconduct.

     This Letter Agreement shall be binding upon, and shall inure to the benefit
of, the Company and you and its and your respective permitted successors,
assigns, heirs, beneficiaries and representatives. This Letter Agreement is
personal to you and may not be assigned by you without the prior written consent
of the Company. Any attempted assignment in violation of this paragraph shall be
null and void. This Letter Agreement shall constitute the entire agreement among
the parties with respect to the matters covered hereby and shall supersede all
previous written, oral or implied understandings among them with respect to such
matters.

     We are excited about your involvement with the Company and look forward to
a long and mutually rewarding scientific and business relationship.

<PAGE>

     For our records, I would appreciate your countersigning the attached copy
of this Letter Agreement and returning the same to me at your earliest
convenience.

                                     Sincerely,

                                     PHASE III MEDICAL, INC.

                                     By:   /s/ Mark Weinreb
                                           ----------------
                                           Mark Weinreb, President & CEO

Accepted and agreed to:

/s/ Robert Aholt
----------------
Robert Aholt

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}]]